Federal Register of Legislation - Australian Government

Primary content

PB 7 of 2020 Arrangements as made
The instrument amends the National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010 (PB 118 of 2010) to add, delete and make changes to drugs, forms, manners of administration, brands, responsible persons and maximum amounts for various pharmaceutical benefits available under the Paraplegic and Quadriplegic Program.
Administered by: Health
Registered 30 Jan 2020
Tabling HistoryDate
Tabled HR04-Feb-2020
Tabled Senate04-Feb-2020
Date of repeal 15 May 2020
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

PB 7 of 2020

 

National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2020 (No. 1)

 

National Health Act 1953

___________________________________________________________________________

 

I, BEN SLADIC, Assistant Secretary, Pharmacy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Amendment Instrument under subsection 100(2) of the National Health Act 1953.

Dated         29 January 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BEN SLADIC

Assistant Secretary

Pharmacy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1       Name of Instrument

(1)          This Instrument is the National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2020 (No. 1).

(2)          This Instrument may also be cited as PB 7 of 2020.

2       Commencement

This Instrument commences on 1 February 2020.

3       Amendments to National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010

Schedule 1 amends the National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010 (PB 118 of 2010).

 


Schedule 1     Amendments

[1]        Schedule 1, entry for Macrogol 3350 in the form Sachets containing powder for oral solution 13.125g with electrolytes, 30

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

 

 

 

APOHEALTH Macrogol with Electrolytes

GX

2

[2]        Schedule 2, details relevant to Responsible Person code AE

omit from the column headed “Responsible Person”: AFT Pharmaceuticals Pty Ltd                       substitute: AFT Pharmaceuticals (AU) Pty Ltd

[3]        Schedule 2, after details relevant to Responsible Person code GO

insert:

GX

Apotex Pty Ltd

52 096 916 148

[4]        Schedule 2, details relevant to Responsible Person code KY

omit from the column headed “Australian Business Number”: 21 001 215 310                substitute: 21 001 215 130

[5]        Schedule 2, details relevant to Responsible Person code RF

omit from the column headed “Australian Business Number”: 33 605 909 911                      substitute: 35 605 909 920

[6]        Schedule 2, details relevant to Responsible Person code RW

omit from the column headed “Australian Business Number”: 33 605 909 911                      substitute: 35 605 909 920

[7]        Schedule 2, details relevant to Responsible Person code VZ

substitute:

VZ

Sanofi-aventis Healthcare Pty Ltd

43 076 651 959